Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections. Issue 3 (4th March 2022) - Rizvi, Ali A.; Linhart, Ales; Vrablik, Michal; Liberopoulos, Evangelos; Rizzo, Manfredi